I think they were blindsided by the FDA. The FDA saw prototypes and must've given no indication of any issues. If they did then surely BOT management would've rectified the problem. They've launched 30 previous products over their careers.
I'm doubting this was due to management incompetence.
Ann: FDA Letter Requires Patient Instruction Update, page-161
-
- There are more pages in this discussion • 135 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add BOT (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
41.5¢ |
Change
-0.005(1.19%) |
Mkt cap ! $751.1M | |||
| Open | High | Low | Value | Volume |
| 41.5¢ | 42.5¢ | 40.0¢ | $2.133M | 5.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 51664 | 40.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 41.5¢ | 341870 | 4 |
View Market Depth
| Last trade - 16.10pm 05/09/2024 (20 minute delay) ? |
| BOT (ASX) Chart |